Unique ID issued by UMIN | UMIN000016603 |
---|---|
Receipt number | R000018276 |
Scientific Title | A feasibility study of carboplatin desensitization protocol in ovarian cancer |
Date of disclosure of the study information | 2015/02/23 |
Last modified on | 2016/02/24 08:59:38 |
A feasibility study of carboplatin desensitization protocol in ovarian cancer
A feasibility study of carboplatin desensitization protocol in ovarian cancer
A feasibility study of carboplatin desensitization protocol in ovarian cancer
A feasibility study of carboplatin desensitization protocol in ovarian cancer
Japan |
ovarian cancer
Hematology and clinical oncology | Clinical immunology | Obstetrics and Gynecology |
Malignancy
NO
We prospectively examine the efficacy and safety of desensitization protocol with ovarian cancer patients who have experienced hypersensitive reaction.
Safety,Efficacy
Exploratory
Phase II
Completion rate of desensitization protocol
Efficacy
Progression free survival
Overall survival
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Carboplatin
desensitization
every 3 or 4 weeks
20 | years-old | <= |
Not applicable |
Female
1)Patients need a histologically or cytologically diagnosis of ovarian malignancy(including peritoneal cancer and fallopian tube cancer).
2)Platinum-free interval > 6 monthes.
3)They are 20 years or older.
4)They have Eastern Cooperative Oncology Group(ECOG)performance status of 0-2.
5)They have experienced hypersensitive reaction with carboplatin.
6)They have adequate organ functions.
7)Written informed consent by the patient.
1)Continuous medication with antihistamine.
2)Active systemic infections to be treated.
3)Active multiple primart cancer (prognosis < 12 monthes)
4)With severe complications.
5)Women during pregnancy, possible pregnancy, or breast-feeding.
6)Psychiatric disease.
7)Continuous systemic steroid treatment.
8)doctor's decision not to be registered to this study.
20
1st name | |
Middle name | |
Last name | Koji Matsumoto |
Hyogo Cancer Center
Division of Medical Oncology
13-70, Kita-oji, Akashi, Hyogo, Japan
078-929-1151
kojmatsu@hp.pref.hyogo.jp
1st name | |
Middle name | |
Last name | Koji Matsumoto |
Hyogo Cancer Center
Division of Medical Oncology
13-70, Kita-oji, Akashi, Hyogo, Japan
078-929-1151
kojmatsu@hp.pref.hyogo.jp
Hyogo Cancer Center
Hyogo Cancer Center
Local Government
NO
兵庫県立がんセンター(兵庫県)
日本医大武蔵小杉病院(神奈川県)
2015 | Year | 02 | Month | 23 | Day |
Unpublished
Open public recruiting
2015 | Year | 02 | Month | 06 | Day |
2015 | Year | 02 | Month | 23 | Day |
2018 | Year | 03 | Month | 31 | Day |
2018 | Year | 03 | Month | 31 | Day |
2018 | Year | 03 | Month | 31 | Day |
2018 | Year | 03 | Month | 31 | Day |
2015 | Year | 02 | Month | 22 | Day |
2016 | Year | 02 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018276
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |